NervGen Pharma
NasdaqCM:NGEN
C$ 3,92
C$-0,01 (-0,25%)
3,92 C$
C$-0,01 (-0,25%)
End-of-day quote: 04/24/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

C$-0,33
Earnings Per Share
C$0,00
Revenue Per Share
0,00%
Gross Margin %
C$0,32 B
Market Cap
C$0,00 B
Long-Term Debt
Earnings Per Share
C$-0,33
Revenue Per Share
C$0,00
Gross Margin %
0,00%
Market Cap
C$0,32 B
Long-Term Debt
C$0,00 B

Financials

Year Year 2025 2024 2023 2022 2021
EPS Earnings Per Share C$-0,60 C$-0,33 C$-0,38 C$-0,43 C$-0,31
Earnings Earnings C$-42,59M C$-23,43M C$-26,57M C$-25,43M C$-14,33M
RPS Revenue Per Share C$0,00 C$0,00 C$0,00 C$0,00 C$0,00
Revenue Revenue C$0,00M C$0,00M C$0,00M C$0,00M C$0,00M
OCF Operating Cash Flow C$-21,31M C$-16,84M C$-17,78M C$-17,78M C$-8,27M
FCF Free Cash Flow C$-26,40M C$-16,84M C$0,00M C$-17,81M C$-8,27M
OM Operating Margin 0,00% 0,00% 0,00% 0,00% 0,00%
GM % Gross Margin % 0,00% 0,00% 0,00% 0,00% 0,00%
FCFS Free Cash Flow Per Share C$0,00 C$-0,25 C$-0,19 C$-0,34 C$-0,21
LT Debt Long-Term Debt N/A N/A N/A N/A N/A
Sha. Stocks 70,99M 70,99M 69,93M 59,13M 46,23M
×